A carregar...

New Acetylcholinesterase Inhibitors for Alzheimer's Disease

Acetylcholinesterase (AChE) remains a highly viable target for the symptomatic improvement in Alzheimer's disease (AD) because cholinergic deficit is a consistent and early finding in AD. The treatment approach of inhibiting peripheral AchE for myasthenia gravis had effectively proven that AchE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mehta, Mona, Adem, Abdu, Sabbagh, Marwan
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3246720/
https://ncbi.nlm.nih.gov/pubmed/22216416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/728983
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!